# EDGAR Filing Document

**Accession Number:** 0000899923
**File Stem:** 0000899923-26-000024
**Filing Date:** 2026-3
**Character Count:** 2405
**Document Hash:** 6696d8a03fb6fab9ddf5d00d5418431b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899923-26-000024.hdr.sgml**: 20260401

**ACCESSION NUMBER**: 0000899923-26-000024

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MYRIAD GENETICS INC
- **CENTRAL INDEX KEY:** 0000899923
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870494517
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 322 NORTH 2200 WEST
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84116
- **BUSINESS PHONE:** 801-584-3600

**MAIL ADDRESS:**
- **STREET 1:** 322 NORTH 2200 WEST
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84116

**Myriad Genetics, Inc.**

**322 North 2200 West**

**Salt Lake City, UT 84116**

March 2, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards

Re:&nbsp;&nbsp;&nbsp;&nbsp;**Myriad Genetics, Inc.**

**Registration Statement on Form S-3**

**Filed February 24, 2026**

**File No. 333-293681 (the "Registration Statement")**

**Acceleration Request**

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Myriad Genetics, Inc. (the "Registrant") hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date and time of the above-referenced Registration Statement to Wednesday, March 4, 2026, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please contact Daniel T. Kajunski, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-1715 with any questions regarding this request.

Very truly yours,

MYRIAD GENETICS, INC.

<u>/s/ Samraat S. Raha&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Samraat S. Raha

President and Chief Executive Officer

cc:&nbsp;&nbsp;&nbsp;&nbsp;*<u>Myriad Genetics, Inc.</u>*

&nbsp;&nbsp;&nbsp;&nbsp;Justin D. Hunter, Senior Vice President, Legal Affairs, Corporate Secretary

<br>